by TractManager | Apr 19, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of specific lots of the Medtronic HeartWare HVAD battery cables, data cables, adapter cables, and controller 2.0 ports due to risk of wear and tear. The HeartWare Ventricular Assist Device (HVAD) cables and...
by TractManager | Apr 15, 2021 | Emerging Technology Report
Breyanzi (lisocabtagene maraleucel [liso-cel]) is an autologous chimeric antigen receptor (CAR) T-cell therapy, a novel type of immunotherapy in which a patient’s own immune cells are genetically re-programmed to target and attack cancer cells. It is indicated for the...
by TractManager | Apr 13, 2021 | News
These safety communications were recently posted by the Food and Drug Administration (FDA):Medtronic ICD and CRT-D Recall The FDA has announced a Class I recall of Medtronic’s Evera and Visia implantable cardioverter defibrillators (ICDs) and Viva, Claria, Amplia, and...
by TractManager | Apr 13, 2021 | Molecular Test Assessment
This report evaluates the analytical validity, clinical validity, and clinical utility of the Prospera test. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 12, 2021 | News
The Food and Drug Administration (FDA) has announced a Class I recall of the Medtronic Valiant Navion Thoracic Stent Graft System due to stent fractures and endoleak concerns.The Valiant Navion Thoracic Stent Graft System is designed to repair lesions of the...
Recent Comments